...
Dive | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||
|
In 1985, she was Director director of the Division of Bacterial Products and worked in Building 29, Room 122A. By 1990, she was the Director director of the Office of Vaccine Research and Review at the Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) where she worked in Building 29B, Room 1H16. In 1995, Dr. Hardegree was became the Director director of the Office of Biologics Research and she returned to working in Building 29, Room 122A. She retired in 1999 as the Director director of the Office of Vaccines Research and Review at CBER.
Dr. Hardegree served on various committees including the World Health Organization (WHO) Steering Committee on Immunization Safety, the National Vaccine Advisory Committee’s Pandemic Influenza Working Group, the Institute of Medicine Vaccine Safety Forum, and the Institute of Medicine Committee to Study the Interaction of Drugs, Biologics, and Chemicals in Deployed U.S. Military Forces.
Her awards include the Department of Health and Human Services Secretary's Award for Distinguished Service and the Food and Drug Administration Distinguished Alumnus Award. She received the FDA Distinguished Alumnus Award in 1999 for outstanding contributions to the Agency’s FDA's public health mission by oversight of the development, licensing, and use of safe and effective childhood vaccines.
Info |
---|
Dr. Hardegree worked in Building 29, Room 418 in 1969, 1971, and 1972. After the Division of Biologics Standards was transferred administratively to the FDA, she was in Building 29, Room 414 in 1980, and Room 122A in 1985 and 1995. She worked in Building 29B at the end of her career. |
...